Literature DB >> 21700959

The milieu of damaged alveolar epithelial type 2 cells stimulates alveolar wound repair by endogenous and exogenous progenitors.

Susan Buckley1, Wei Shi, Gianni Carraro, Sargis Sedrakyan, Stefano Da Sacco, Barbara A Driscoll, Laura Perin, Roger E De Filippo, David Warburton.   

Abstract

Alveolar epithelial integrity is dependent upon the alveolar milieu, yet the milieu of the damaged alveolar epithelial cell type 2 (AEC2) has been little studied. Characterization of its components may offer the potential for ex vivo manipulation of stem cells to optimize their therapeutic potential. We examined the cytokine profile of AEC2 damage milieu, hypothesizing that it would promote endogenous epithelial repair while recruiting cells from other locations and instructing their engraftment and differentiation. Bronchoalveolar lavage and lung extract from hyperoxic rats represented AEC2 in vivo damage milieu, and medium from a scratch-damaged AEC2 monolayer represented in vitro damage. CINC-2 and ICAM, the major cytokines detected by proteomic cytokine array in AEC2 damage milieu, were chemoattractive to normoxic AECs and expedited in vitro wound healing, which was blocked by their respective neutralizing antibodies. The AEC2 damage milieu was also chemotactic for exogenous uncommitted human amniotic fluid stem cells (hAFSCs), increasing migration greater than 20-fold. hAFSCs attached within an in vitro AEC2 wound and expedited wound repair by contributing cytokines migration inhibitory factor and plasminogen activator inhibitor 1 to the AEC2 damage milieu, which promoted wound healing. The AEC2 damage milieu also promoted differentiation of a subpopulation of hAFSCs to express SPC, TTF-1, and ABCA3, phenotypic markers of distal alveolar epithelium. Thus, the microenvironment created by AEC2 damage not only promotes autocrine repair but also can attract uncommitted stem cells, which further augment healing through cytokine secretion and differentiation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21700959      PMCID: PMC3262671          DOI: 10.1165/rcmb.2010-0325OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  38 in total

1.  Isolation of amniotic stem cell lines with potential for therapy.

Authors:  Paolo De Coppi; Georg Bartsch; M Minhaj Siddiqui; Tao Xu; Cesar C Santos; Laura Perin; Gustavo Mostoslavsky; Angéline C Serre; Evan Y Snyder; James J Yoo; Mark E Furth; Shay Soker; Anthony Atala
Journal:  Nat Biotechnol       Date:  2007-01-07       Impact factor: 54.908

2.  Threshold of lung injury required for the appearance of marrow-derived lung epithelia.

Authors:  Erica L Herzog; John Van Arnam; BuQu Hu; Diane S Krause
Journal:  Stem Cells       Date:  2006-08       Impact factor: 6.277

3.  Macrophage dysfunction and susceptibility to pulmonary Pseudomonas aeruginosa infection in surfactant protein C-deficient mice.

Authors:  Stephan W Glasser; Albert P Senft; Jeffrey A Whitsett; Melissa D Maxfield; Gary F Ross; Theresa R Richardson; Daniel R Prows; Yan Xu; Thomas R Korfhagen
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

4.  Disparate mechanisms of sICAM-1 production in the peripheral lung: contrast between alveolar epithelial cells and pulmonary microvascular endothelial cells.

Authors:  Michael P Mendez; Susan B Morris; Steven Wilcoxen; Ming Du; Yeni K Monroy; Henriette Remmer; Hedwig Murphy; Paul J Christensen; Robert Paine
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-02-15       Impact factor: 5.464

5.  Protective effect of human amniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis.

Authors:  Laura Perin; Sargis Sedrakyan; Stefano Giuliani; Stefano Da Sacco; Gianni Carraro; Liron Shiri; Kevin V Lemley; Michael Rosol; Sam Wu; Anthony Atala; David Warburton; Roger E De Filippo
Journal:  PLoS One       Date:  2010-02-24       Impact factor: 3.240

Review 6.  Potential application of mesenchymal stem cells in acute lung injury.

Authors:  Jae Woo Lee; Naveen Gupta; Vladimir Serikov; Michael A Matthay
Journal:  Expert Opin Biol Ther       Date:  2009-10       Impact factor: 4.388

Review 7.  Genetic disorders of surfactant dysfunction.

Authors:  Susan E Wert; Jeffrey A Whitsett; Lawrence M Nogee
Journal:  Pediatr Dev Pathol       Date:  2009 Jul-Aug

8.  TGF-beta signaling promotes survival and repair in rat alveolar epithelial type 2 cells during recovery after hyperoxic injury.

Authors:  S Buckley; W Shi; L Barsky; D Warburton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-02-01       Impact factor: 5.464

9.  Engraftment of bone marrow-derived stem cells to the lung in a model of acute respiratory infection by Pseudomonas aeruginosa.

Authors:  Joanna Rejman; Carla Colombo; Massimo Conese
Journal:  Mol Ther       Date:  2009-05-05       Impact factor: 11.454

10.  IL-6 protects against hyperoxia-induced mitochondrial damage via Bcl-2-induced Bak interactions with mitofusins.

Authors:  Aaron B Waxman; Narasaiah Kolliputi
Journal:  Am J Respir Cell Mol Biol       Date:  2009-01-23       Impact factor: 6.914

View more
  20 in total

Review 1.  Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012.

Authors:  Daniel J Weiss
Journal:  Ann Am Thorac Soc       Date:  2013-10

2.  Activation of type II cells into regenerative stem cell antigen-1(+) cells during alveolar repair.

Authors:  Yuru Liu; Varsha Suresh Kumar; Wei Zhang; Jalees Rehman; Asrar B Malik
Journal:  Am J Respir Cell Mol Biol       Date:  2015-07       Impact factor: 6.914

3.  Modulating the alveolar milieu to enhance resolution of fibrotic lung injury.

Authors:  Orquidea Garcia; Sue Buckley; Sonia Navarro; Barbara Driscoll; David Warburton
Journal:  Proc Am Thorac Soc       Date:  2012-07

Review 4.  Concise review: current status of stem cells and regenerative medicine in lung biology and diseases.

Authors:  Daniel J Weiss
Journal:  Stem Cells       Date:  2014-01       Impact factor: 6.277

5.  Human induced pluripotent stem cells ameliorate hyperoxia-induced lung injury in a mouse model.

Authors:  Adam Mitchell; Heather Wanczyk; Todd Jensen; Christine Finck
Journal:  Am J Transl Res       Date:  2020-01-15       Impact factor: 4.060

Review 6.  CD117(+) amniotic fluid stem cells: state of the art and future perspectives.

Authors:  Mara Cananzi; Paolo De Coppi
Journal:  Organogenesis       Date:  2012-07-01       Impact factor: 2.500

7.  Amniotic fluid stem cells prevent β-cell injury.

Authors:  Valentina Villani; Anna Milanesi; Sargis Sedrakyan; Stefano Da Sacco; Susanne Angelow; Maria Teresa Conconi; Rosa Di Liddo; Roger De Filippo; Laura Perin
Journal:  Cytotherapy       Date:  2013-11-07       Impact factor: 5.414

8.  Endoplasmic reticulum stress response is activated in pulmonary hypoplasia secondary to congenital diaphragmatic hernia, but is decreased by administration of amniotic fluid stem cells.

Authors:  Areti Tzanetakis; Lina Antounians; Alyssa Belfiore; Qi Ma; Mark Stasiewicz; Ornella Pellerito; Augusto Zani
Journal:  Pediatr Surg Int       Date:  2018-11-01       Impact factor: 1.827

Review 9.  The pathogenesis of COPD and IPF: distinct horns of the same devil?

Authors:  Marco Chilosi; Venerino Poletti; Andrea Rossi
Journal:  Respir Res       Date:  2012-01-11

10.  HMGB1 accelerates alveolar epithelial repair via an IL-1β- and αvβ6 integrin-dependent activation of TGF-β1.

Authors:  Jean-François Pittet; Hidefumi Koh; Xiaohui Fang; Karen Iles; Sarah Christiaans; Naseem Anjun; Brant M Wagener; Dae Won Park; Jaroslaw W Zmijewski; Michael A Matthay; Jérémie Roux
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.